We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Joint Corp ((JYNT - Free Report) ) has been posting some impressive topline growth and that has helped propel some recent earnings estimate revision to the upside. When estimates move higher so does the Zacks Rank and this stock has the highest Zacks Rank #1 (Strong Buy) and it is the Bull of the Day.
Description
The Joint Corp. is a healthcare franchisor of chiropractic clinics. The Company's plans include: Single Visit, Premium Wellness Plan and Wellness Plan. It also provides a family wellness plan. The Company also provides removal of subluxations. It operates its clinics across: Albany, New York; Austin, Texas; Brentwood, California; Fort Mill, South Carolina; Lubbock, Texas; Lynnwood, Washington; Middletown, New Jersey; San Antonio, Texas; San Diego, California and Spartanburg, South Carolina, among others. The Joint Corp. is headquartered in Scottsdale, Arizona.
Earnings History
The earning history is pretty good for JYNT. Over the last four quarters I see two beats, one miss and one NA on the Zacks website. There was no estimate data for one quarter, but looking back at the price and consensus and EPS surprise chart (https://www.zacks.com/stock/chart/JYNT/price-consensus-eps-surprise-chart) you can see of the last 6 quarters where Zacks had estimates, there were 5 beats and one miss.
In looking at the topline for this name, I saw this chart in a company provided presentation:
Revenue growth like that is just what I love to see. Consistent revenue growth tends to help bring in new buyers to a stock.
Estimate Revisions
The Zacks Rank is an algorithm that is based on the movement of earnings estimates over the last 60 days. For JYNT, I see a positive one penny move for this quarter and nothing for next quarter.
The full year 2019 EPS consensus estimate has risen from $0.21 to $0.23. The 2020 EPS consensus estimate has moved from $0.52 to $0.54.
Those two cent moves don’t seem like much but the implied growth rate is what is really attracting more and more investors to this story.
Valuation
JYNT has some lofty numbers in the valuation department. That style score grade of F is hard to swallow, as is a 124x trailing PE and 77x forward multiple. Given the franchise model, the book value is very low, so the 116x price to book multiple is going to keep that Zacks Value Style Score at an F for some time. That said, the 50% annual topline growth rate is going to draw a lot of attention, even with a 6.8x price to sales multiple.
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
Bull Of The Day: The Joint Corp (JYNT)
The Joint Corp ((JYNT - Free Report) ) has been posting some impressive topline growth and that has helped propel some recent earnings estimate revision to the upside. When estimates move higher so does the Zacks Rank and this stock has the highest Zacks Rank #1 (Strong Buy) and it is the Bull of the Day.
Description
The Joint Corp. is a healthcare franchisor of chiropractic clinics. The Company's plans include: Single Visit, Premium Wellness Plan and Wellness Plan. It also provides a family wellness plan. The Company also provides removal of subluxations. It operates its clinics across: Albany, New York; Austin, Texas; Brentwood, California; Fort Mill, South Carolina; Lubbock, Texas; Lynnwood, Washington; Middletown, New Jersey; San Antonio, Texas; San Diego, California and Spartanburg, South Carolina, among others. The Joint Corp. is headquartered in Scottsdale, Arizona.
Earnings History
The earning history is pretty good for JYNT. Over the last four quarters I see two beats, one miss and one NA on the Zacks website. There was no estimate data for one quarter, but looking back at the price and consensus and EPS surprise chart (https://www.zacks.com/stock/chart/JYNT/price-consensus-eps-surprise-chart) you can see of the last 6 quarters where Zacks had estimates, there were 5 beats and one miss.
In looking at the topline for this name, I saw this chart in a company provided presentation:
Revenue growth like that is just what I love to see. Consistent revenue growth tends to help bring in new buyers to a stock.
Estimate Revisions
The Zacks Rank is an algorithm that is based on the movement of earnings estimates over the last 60 days. For JYNT, I see a positive one penny move for this quarter and nothing for next quarter.
The full year 2019 EPS consensus estimate has risen from $0.21 to $0.23. The 2020 EPS consensus estimate has moved from $0.52 to $0.54.
Those two cent moves don’t seem like much but the implied growth rate is what is really attracting more and more investors to this story.
Valuation
JYNT has some lofty numbers in the valuation department. That style score grade of F is hard to swallow, as is a 124x trailing PE and 77x forward multiple. Given the franchise model, the book value is very low, so the 116x price to book multiple is going to keep that Zacks Value Style Score at an F for some time. That said, the 50% annual topline growth rate is going to draw a lot of attention, even with a 6.8x price to sales multiple.
Chart
The Joint Corp. Price, Consensus and EPS Surprise
The Joint Corp. price-consensus-eps-surprise-chart | The Joint Corp. Quote
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>